Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Daré Bioscience, Inc. to Present at the LD Micro 10th Annual Main Event Conference
SAN DIEGO , Dec. 04, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a healthcare company committed to the development and commercialization of innovative products in women's reproductive health, today announced that Sabrina Martucci Johnson , President and Chief Executive Officer,
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the 2017 BIO Investor Forum
SAN DIEGO , Oct. 10, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's reproductive health, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer,
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
SAN DIEGO , Sept. 07, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a healthcare company committed to the development and commercialization of innovative products in women's reproductive health, today announced that Sabrina Martucci Johnson , Chief Executive Officer and Founder,
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the Liolios 6th Annual Gateway Conference
SAN DIEGO , Aug. 30, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a healthcare company committed to the development and commercialization of innovative products in women's reproductive health, today announced that Sabrina Martucci Johnson , Chief Executive Officer and Founder, will
View HTML
Toggle Summary Daré Bioscience, Inc. CEO Featured in San Diego Business Journal Article on Women Founders
SAN DIEGO , Aug. 15, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) and the CEO, Sabrina Martucci Johnson , were featured in a San Diego Business Journal article published on August 14, 2017 titled Women Founders: How to get Men to Relate.
View HTML
Toggle Summary Daré Bioscience, Inc. Discusses Key Goals with Wall Street Analyzer
SAN DIEGO , Aug. 03, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) discussed with Wall Street Analyzer key goals over the next twenty-four months, including the Ovaprene ® clinical development program, the memorandum of understanding with CONRAD to enter into an agreement in
View HTML
Toggle Summary Daré Bioscience, Inc. announces Memorandum of Understanding with CONRAD for the conduct of the Ovaprene® postcoital test clinical trial
SAN DIEGO , July 24, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) announced today that it has entered into a memorandum of understanding with CONRAD to enter into an agreement in connection with a postcoital test (PCT) clinical trial of Ovaprene®, wherein CONRAD will provide certain
View HTML
Toggle Summary Daré Bioscience, Inc. trading on The NASDAQ Capital Market under the symbol "DARE"
Company focused on the development and commercialization of women's reproductive health products Daré to Host Conference Call on Monday, July 24, 2017 , at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time to Discuss Business Opportunity SAN DIEGO , July 20, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience,
View HTML
Toggle Summary Cerulean Pharma and Daré Bioscience Announce Closing and New Stock Symbol, "DARE"
WALTHAM, Mass. & SAN DIEGO --(BUSINESS WIRE)-- Cerulean Pharma Inc. (NASDAQ:CERU) and Daré Bioscience Operations, Inc. (formerly Daré Bioscience, Inc. ) today announced the closing of the transactions contemplated by the stock purchase agreement entered into by the companies on March 19, 2017 .
View HTML
Toggle Summary Daré Bioscience Distributes Letter to Cerulean Stockholders Outlining Value Proposition and Requesting Favorable Vote at Upcoming Special Stockholder Meeting
WALTHAM, Mass. & SAN DIEGO --(BUSINESS WIRE)-- Cerulean Pharma Inc. (NASDAQ:CERU) and Daré Bioscience, Inc. today announced that Daré Founder and CEO Sabrina Martucci Johnson mailed the following letter to Cerulean stockholders of record at the close of business on June 9, 2017 outlining the Daré
View HTML